202 results
8-K
EX-99.1
CYDY
CytoDyn Inc.
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
) changes in foreign, political, and social conditions; (xvi) stockholder actions or proposals with regard to the Company, its management, or its board
424B3
CYDY
CytoDyn Inc.
22 Nov 23
Prospectus supplement
12:16pm
affecting the Company or its products; (xiv) general economic and business conditions; (xv) changes in foreign, political, and social conditions; (xvi
8-K
EX-99.1
CYDY
CytoDyn Inc.
21 Nov 23
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
5:15pm
; (xv) changes in foreign, political, and social conditions; (xvi) stockholder actions or proposals with regard to the Company, its management, or its
424B3
CYDY
CytoDyn Inc.
24 Oct 23
Prospectus supplement
6:01am
economic and business conditions; changes in foreign, political, and social conditions; stockholder actions or proposals with regard to the Company
424B3
aclo 50qmdrhc2v1
10 Oct 23
Prospectus supplement
6:02pm
POS AM
2yqi7cf4 e7j8tkkx
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm
424B3
qetajn abh
11 Jul 23
Prospectus supplement
5:28pm
8-K
EX-99.1
ji6pm5
11 Jul 23
CytoDyn Announces Company Updates and Investment Community Update Webcast
4:20pm
8-K
EX-99.1
8y7yip4rt ne6
24 May 23
CytoDyn Announces President Takes Medical Leave of Absence
5:15pm
DEFA14A
crxxfpd2r904rwvx7b
7 Dec 22
Additional proxy soliciting materials
11:02am
8-K
EX-99.1
bzjqqwop0n21voxmm6n3
7 Dec 22
Regulation FD Disclosure
11:00am
8-K
EX-99.1
gf7aggfq
28 Oct 22
CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues
5:15pm
424B3
j2gyw5lj5mqfnijj
2 Sep 22
Prospectus supplement
5:13pm